Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an adjuvant to superficial cervical block for carotid endarterectomy
ACTRN12622000942752Phase 4Recruiting
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine, levobupivacaine and lidocaine in carotid atheroma (CAS) (2 arms), sponsored by University Hospital Center Sestre milosrdnice. Primary endpoints: Onset of sensory block, Duration of sensory block and 1 more. Started Sep 2021; status: recruiting.
02
Drugs
dexmedetomidinelevobupivacainelidocaine
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on ACTRN12622000942752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622000942752.